Cover storyCDMO Trends 2026: What’s Driving Mergers And Acquisitions
CDMO trends 2026 show a structural consolidation wave — bigger deals, sharper specialization, and rising onshoring pressure reshaping manufacturing.
Cover storyCDMO trends 2026 show a structural consolidation wave — bigger deals, sharper specialization, and rising onshoring pressure reshaping manufacturing.

PacBio ships SPRQ-Nx for Vega, adding 21 CFR Part 11 audit logging and 90 Gb HiFi yield to benchtop long-read sequencing.

Optimal Balance Pharmacy recalls one lot of compounded glutathione 200 mg/mL multi-dose vials after internal testing found elevated bacterial endotoxin levels.

FDA grants accelerated approval to Ultragenyx's Genglycos, the first gene therapy for GSD1a, based on a 48-week surrogate endpoint trial.

Tilray scales cultivation to 275 MT across EU-GMP-certified sites in Canada and Portugal, reshaping international medical cannabis supply chains.
Latest edition

Sep 28
Feb 03From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
